A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
Clinical trial NCT07231952 · RECRUITING
Trial details
- NCT number
- NCT07231952
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-11
- Primary completion
- 2028-04-11
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.